4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-24-002019
Options or other derivatives
- President and Chief Executive acquired 475,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Curran Terrie President and Chief Executive | 2024-01-18 | Grant or award · Stock Option (Right to Buy) | +475,000 | 475,000 | D | ||
Loading xslF345X05/doc4.xml…